Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of Duloxetine in Healthy Females
NCT02232542Phase 1Completed
- Sponsor
- Boehringer Ingelheim
- Start
- Jun 2003
- Primary completion
- Aug 2003
- Modality
- Small Molecules
01
Overview
Phase 1, randomised, double-blind trial of duloxetine in stress urinary incontinence (SUI) (3 arms), sponsored by Boehringer Ingelheim. Primary endpoints: Assessment of tolerability by investigator, Number of subjects with adverse events and 3 more. Started Jun 2003; status: completed.
02
Drugs
duloxetine
03
Conditions
stress urinary incontinence (SUI)
Beyond the preview
Go deeper on NCT02232542.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02232542.